Chemokine mRNA alterations in newborn and adult mouse lung during acute hyperoxia

Experimental Lung Research

Volumn 24, Issue 5, 1998, Pages 685-702

  D'Angio, Carl T ^a,b   Johnston, Carl J ^a   Wright, Terry W ^a   Reed, Christina K ^a   Finkelstein, Jacob N ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b Golisano Childrens Hospital at Strong   (United States)

Author keywords

Acute Lung Injury; C57BL 5 Mice; Inflammatory Cells; Interferon Induced Protein 10 (IP 10); Macrophage Inflammatory Protein 1 (MIP 1 ); Macrophage Inflammatory Protein 2 (MIP 2); Monocyte Chemoattractant Protein 1 (MCP 1); Oxygen Injury

Indexed keywords

CHEMOKINE; GAMMA INTERFERON; MACROPHAGE INFLAMMATORY PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FETUS LUNG MATURATION; HYPEROXIA; IN SITU HYBRIDIZATION; INFLAMMATORY CELL; LUNG ALVEOLUS EPITHELIUM; LUNG INJURY; MESSENGER RNA SYNTHESIS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; TISSUE SECTION;

EID: 0031684430     PISSN: 01902148     EISSN: None     Source Type: Journal    
DOI: 10.3109/01902149809099588     Document Type: Article

References (40)

1. Frank L, Bucher JR, Roberts RJ: Oxygen toxicity in neonatal and adult animals of various species. J Appl Physiol: Respir Envir Exercise Physiol. 1978;45:699-704.
2. Holm BA, Matalon S, Finkelstein JN, Notter RH: Type II pneumocyte changes during hyperoxic lung injury and recovery. J Appl Physiol. 1988;65:2672-2678.
3. Bonikos DS, Bensch KG, Northway WH Jr: Oxygen toxicity in the newborn. The effect of chronic continuous 100 percent oxygen exposure on the lungs of newborn mice. Am J Pathol. 1976;85:623-650.
4. Veness-Meehan KA, Rhodes DN, Stiles AD: Temporal and spatial expression of biglycan in chronic oxygen-induced lung injury. Am J Respir Cell Mol Biol. 1994;11:509-516.
5. D'Angio CT, Finkelstein JN, Lomonaco MB, Pahia A, Wright SA, Baggs RB, Notter RH, Ryan RM: Changes in surfactant protein gene expression in a neonatal rabbit model of hyperoxia-induced fibrosis. Am J Physiol: Lung Cell Mol Physiol. 1997;16:L720-L730.
6. Frank L: Development aspects of experimental pulmonary oxygen toxicity. Free Radic Biol Med. 1991;11:463-494.
7. Johnston CJ, Wright TW, Reed CK, Finkelstein JN: Comparison of adult and newborn pulmonary cytokine mRNA expression after hyperoxia. Exp Lung Res. 1997;23:537-552.
8. Baggiolini M, Dewald B, Moser B: Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv Immunol. 1994;55:97-179.
9. Kotecha S, Chan B, Azam N, Silverman M, Shaw RJ: Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease. Arch Dis Chile Fetal Neonat Ed. 1995;72:F90-F96.
10. Groneck, P. Gotze-Speer B, Oppermann M, Eiffert H, Speer CP: Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Pediatr 1994;93:712-718.
11. Jones CA, Cayabyab RG, Kwong KYC, Stotts C, Wong B, Hamdan H, Minoo P, Delemos RA: Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease - a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res. 1996;39:966-975.
12. Little S, Dean T, Bevin S, et al: Role of elevated plasma soluble ICAM-1 and bronchial lavage fluid IL-8 levels as markers of chronic lung disease in premature infants. Thorax. 1995;50:1073-1079.
13. McColm JR, McIntosh N: Interleukin-8 in bronchoalveolar lavage samples as predictor of chronic lung disease in premature infants. Lancet. 1994;343:729.
14. D'Angio CT, Sinkin RA, LoMonaco MB, Finkelstein JN : Interleukin-8 and monocyte chemoattractant protein-1 mRNAs in oxygen-injured rabbit lung. Am J Physiol. 1995;268:L826-L831.
15. Lynch JP III, Standiford TJ, Rolfe MW, Kunkel SL, Stricter RM: Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8. Am Rev Respir Dis. 1992;145:1433-1439.
16. Donnelly SC, Strieter RM, Kunkel SL, Walz A, Robertson CR, Carter DC, Grant IS, Pollok AJ, Haslett C: Chemotactic cytokines in the established adult respiratory distress syndrome and at-risk patients. Chest. 1994;105:98S-99S.
17. Donnelly SC, Strieter RM, Kunkel SL, Walz A, Robertson CR, Carter DC, Grant IS, Pollok AJ, Haslett C: Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet. 1993;341:643-677.
18. Driscoll KE, Simpson L, Carter J, Hassenbein D, Leikauf GD: Ozone inhalation stimulates expression of a neutrophil chemotactic protein, macrophage inflammatory protein 2. Toxicol Appl Pharmacol. 1993;119:306-309.
19. Huang S, Paulauskis JD, Godleski JJ, Kobzik L: Expression of macrophage inflammatory protein-2 and KC mRNA in pulmonary inflammation. Am J Pathol. 1992;141:981-988.
20. Rollins BJ, Morrison ED, Stiles CD: Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties. Proc Natl Acad Sci USA. 1988;85:3738-3742.
21. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
22. Meyuhas O, Perry RP: Construction and identification of cDNA clones for mouse ribosomal proteins: application for the study of r-protein gene expression. Gene 1980;10:113-129.
23. Melton DA, Krieg PA, Rebagliati MR, Maniatis T, Zinn K, Green MR: Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucl Acid Res. 1984;12:7035-7056.
24. Angerer LM, Stoler MH, Angerer RC: In situ hybridization with RNA probes: an annotated recipe. In: Valentino KL, ed. In Situ Hybridization: Applications to Neurobiology. New York: Oxford University Press; 1987:42-70.
25. Dawson-Saunders B, Trapp RG: Basic and Clinical Biostatistics. Norwalk, CT: Appleton and Lange; 1990:329.
26. Driscoll KE, Maurer JK, Hassenbein D, Carter J, Janssen YMW, Mossman BT, Osier M, Oberdörster G: Contributions of macrophage-derived cytokines and cytokine networks to mineral dust-induced inflammation. In: Mohr U, Dungworth DL, Mauderly JL, eds. Toxic and Carcinogenic Effects of Solid Particles in the Respiratory Tract. Washington, DC: ILSI; 1994:170-190.
27. Smith RE: Chemotactic cytokines mediate leukocyte recruitment in fibrotic lung disease. Biol Signals. 1996;5:223-231.
28. Gunn MD, Nelken NA, Liao X, Williams LT: Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation. J Immunol. 1997;158:376-383.
29. Brieland JK, Jones ML, Clarke SJ, Baker JB, Warren JS, Fantone JC: Effect of acute inflammatory lung injury on the expression of monocyte chemoattractant protein-1 (MCP-1) in rat pulmonary alveolar macrophages. Am J Respir Cell Mol Biol. 1992;7:134-139.
30. Rowen JL, Smith CW, Edwards MS: Group B streptococci elicit leukotriene B4 and interleukin-8 from human monocytes: neonates exhibit a diminished response. J Infect Dis. 1995;172:420-426.
31. Stiehm ER, Roberts RL, Ank BJ, Plaeger-Marshall S, Salman N, Shen L, Fanger MW: Comparison of cytotoxic properties of neonatal and adult neutrophils and monocytes and enhancement by cytokines. Clin Diag Lab Immunol. 1994;1:342-347.
32. Marodi L, Kaposzta R, Campbell DE, Polin RA, Csongor J, Johnston RB Jr: Candidacidal mechanisms in the human neonate. Impaired IFN-gamma activation of macrophages in newborn infants. J Immunol 1994;153:5643-5649.
33. Zisman DA, Kunkel SL, Stricter RM, Tsai WC, Bucknell K, Wilkowski J, Standiford TJ: MCP-1 protects mice in lethal endotoxemia. J Clin Investig. 1997;99:2832-2836.
34. Luster AD, Leder P: IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo. J Exp Med. 1993;178:1057-1065.
35. Arenberg DA, Kunkel SL, Polverini PJ, Morris SB, Burdick MD, Glass MC, Taub DT, Iannettoni MD, Whyte RI, Stricter RM: Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J Exp Med. 1996;184:981-992.
36. Bagchi A, Viscardi RM, Taciak V, Ensor JE, McCrea KA, Hasday JD: Increased activity of interleukin-6 but not tumor necrosis factor-alpha in lung lavage of premature infants is associated with the development of bronchopulmonary dysplasia. Pediatr Res. 1994;36:244-252.
37. Grigg JM, Barber A, Silverman M: Increased levels of bronchoalveolar lavage fluid interleukin-6 in preterm ventilated infants after prolonged rupture of membranes. Am Rev Respir Dis. 1992;145:782-786.
38. Rozychi HJ: Bronchoalveolar interleukin-1 beta in infants on day 1 of life. South Med J. 1994;87:991-996.
39. Watterberg KL, Demers LM, Scott SM, Murphy S: Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatr. 1996;97:210-215.
40. O'Brien-Ladner AR, Nelson ME, Cowley BD Jr, Bailey K, Wesselius LJ: Hyperoxia amplifies TNF-alpha production in LPS-stimulated human alveolar macrophages. Am J Respir Cell Mol Biol. 1995;12:275-279.